You have 9 free searches left this month | for more free features.

CTL

Showing 26 - 50 of 549

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

DLBCL (DLBCL) Trial (Tisagenlecleucel)

Withdrawn
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • Tisagenlecleucel
  • (no location specified)
Feb 25, 2022

Lymphoma, Hodgkin's Disease, Relapse Trial in Houston (TGFbeta resistant LMP-specific CTLs)

Active, not recruiting
  • Lymphoma
  • +3 more
  • TGFbeta resistant LMP-specific CTLs
  • Houston, Texas
  • +1 more
Dec 8, 2021

Multiple Sclerosis Trial in Nantes (Cellular therapy with EBV specific autologous CTL infusion)

Recruiting
  • Multiple Sclerosis
  • Cellular therapy with EBV specific autologous CTL infusion
  • Nantes, France
    University Hospital
Jan 27, 2021

Neuroblastoma Trial in Houston (EBV specific CTLs)

Active, not recruiting
  • Neuroblastoma
  • EBV specific CTLs
  • Houston, Texas
    Texas Children's Hospital
Feb 2, 2022

Follicular Lymphoma Trial in Worldwide (tisagenlecleucel)

Active, not recruiting
  • Follicular Lymphoma
  • tisagenlecleucel
  • Duarte, California
  • +29 more
Nov 2, 2022

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Houston (autologous CAR.CD30 EBV specific-CTLs)

Active, not recruiting
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • autologous CAR.CD30 EBV specific-CTLs
  • Houston, Texas
  • +1 more
Feb 4, 2022

DLBCL, Grade 3b Follicular Lymphoma, Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial (biological, procedure, drug,

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • +6 more
  • Axicabtagene Ciloleucel
  • +10 more
  • (no location specified)
Jan 13, 2023

Acute Lymphoblastic Leukemia Trial in Worldwide (CTL019)

Completed
  • Acute Lymphoblastic Leukemia
  • CTL019
  • Wien, Austria
  • +10 more
Jun 30, 2021

Alcohol Use, Underage, Alcohol Problem Drinking, Substance Use Trial in Los Angeles (Mindfulness Based Relapse Prevention,

Completed
  • Alcohol Use, Underage
  • +2 more
  • Mindfulness Based Relapse Prevention
  • Control (CTL)
  • Los Angeles, California
    University of Southern California, School of Social Work
Sep 27, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo, East Hills, West Islip (biological, drug, other)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Abatacept
  • +3 more
  • Buffalo, New York
  • +2 more
Dec 22, 2022

Cytomegalovirus Infections, Hematological Disease Trial in Shanghai (donor derived cytomegalovirus specific T lymphocytes,

Recruiting
  • Cytomegalovirus Infections
  • Hematological Disease
  • donor derived cytomegalovirus specific T lymphocytes
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong University Affilated Shanghai General Hospita
Mar 16, 2021

Epstein-Barr Virus (EBV) Infections, Lymphoproliferative Disorders, EBV+ Associated Lymphoma Trial (tabelecleucel)

Available
  • Epstein-Barr Virus (EBV) Infections
  • +11 more
  • tabelecleucel
  • (no location specified)
Feb 15, 2022

AIDS, BK Virus Infection, Human Immunodeficiency Virus Trial in Houston (Allogeneic BK-specific Cytotoxic T-lymphocytes,

Recruiting
  • Acquired Immunodeficiency Syndrome
  • +7 more
  • Allogeneic BK-specific Cytotoxic T-lymphocytes
  • Laboratory Biomarker Analysis
  • Houston, Texas
    M D Anderson Cancer Center
Oct 29, 2021

B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia, Refractory B-cell Acute Lymphoblastic

Completed
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • CTL019 T-cells
  • Los Angeles, California
  • +12 more
Oct 29, 2020

HIV Trial in United States (ALVAC(2)120(B,MN)GNP (vCP1452), HIV-1 Immunogen)

Completed
  • HIV Infections
  • ALVAC(2)120(B,MN)GNP (vCP1452)
  • HIV-1 Immunogen
  • Los Angeles, California
  • +8 more
Oct 28, 2021

Osteosarcoma, Neuroblastoma Trial in Houston (genetic, biological, drug)

Active, not recruiting
  • Osteosarcoma
  • Neuroblastoma
  • GD2 T cells
  • +3 more
  • Houston, Texas
  • +1 more
Apr 16, 2021

NSCLC, Second-line Treatment Trial in Tianjin (CTL, Toripalimab)

Unknown status
  • Non-small Cell Lung Cancer
  • Second-line Treatment
  • CTL
  • Toripalimab
  • Tianjin, Tianjin, China
  • +1 more
Jul 5, 2020

Mitochondrial Biogenesis Trial in Kingston (BFR Exercise Training, CTL Exercise Training)

Completed
  • Mitochondrial Biogenesis
  • BFR Exercise Training
  • CTL Exercise Training
  • Kingston, Ontario, Canada
    Queen's University
Sep 18, 2020

Therapeutic HIV Vaccination on Control of HIV After

Completed
  • HIV Infections
  • Therapeutic vaccinations from A5058s
  • Torrance, California
  • +13 more
Oct 28, 2021

Gastric Cancer Trial in Jinan (DC vaccine, CTL, Sintilimab Injection)

Recruiting
  • Gastric Cancer
  • DC vaccine
  • +2 more
  • Jinan, Shandong, China
    The 2nd Hospital of Shandong University
Sep 25, 2020

Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Diffuse Large B-cell Lymphoma; Acute Lymphoblastic Leukemia Trial in

Recruiting
  • Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Diffuse Large B-cell Lymphoma; Acute Lymphoblastic Leukemia
  • YTB323 and ibrutinib
  • YTB323 single agent
  • Tampa, Florida
  • +20 more
Feb 24, 2022

Viral Infection, Primary Immune Deficiency Disorder Trial in United States (BK CTL)

Recruiting
  • Viral Infection
  • Primary Immune Deficiency Disorder
  • BK CTL
  • San Francisco, California
  • +5 more
Feb 19, 2021

Extranodal NK/T-cell Lymphoma Trial in Korea, Republic of (VT-EBV-N, Placebo)

Recruiting
  • Extranodal NK/T-cell Lymphoma
  • VT-EBV-N
  • Placebo
  • Busan, Korea, Republic of
  • +7 more
Apr 28, 2022

Amputation, Transfemoral Amputation, Osseointegration Trial in Aurora (Limb Load Biofeedback Training Intervention, Attention

Recruiting
  • Amputation
  • +2 more
  • Limb Load Biofeedback Training Intervention
  • Attention Control
  • Aurora, Colorado
    CU Physical Therapy
Jan 31, 2023